Epicur Pharma® brings a unique advantage to the veterinary industry. The 503B facility manufactures drugs with consistent potency, sterility, and purity from batch to batch.
A division of Stokes Healthcare and a sister company of Stokes Pharmacy, Epicur® was developed in 2016 to align with the Food and Drug Administration’s (FDA) recommended guidelines and requirements for producing high-quality manufactured drugs. The 503B standards put in place reflect current Good Manufacturing Practices (cGMP), the same regulations in place for human pharmaceuticals.
Epicur Pharma® is proud to be a pioneer in animal drug standards, offering the largest selection of manufactured drugs that are traditionally compounded. Our commitment to drug consistency and quality emphasizes our devotion to patient safety.
Our 503B manufactured products have key advantages for veterinarians and patients:
*does not apply to all products
Epicur® is proud to partner with and support AAHA in their commitment to continually raising the standard of care for companion animals.
Still have questions about 503B standards? We have answers for you.
Get a glimpse of the quality processes that ensure every batch of your B products gets our A game.
Get more details about Epicur’s 503B manufactured products and how they can make a difference in patient outcomes.